Latest Posts:
Search for:
Archive

July 2025

Browsing
In Pharmaceuticals & Biotech

EU and German Courts Clarify Rules on Rx Drug Discounts in latest DocMorris decisions

by , and 7 Mins Read

With its ruling in Apothekerkammer Nordrhein v. DocMorris (Case C-517/23), the Court of Justice of the European Union (CJEU) provided further clarity on the interpretation of EU law concerning the advertising of medicinal products, with a particular emphasis on prescription-only (Rx) medicinal products. Most importantly, the CJEU ruled that advertising unspecified Rx medicinal products by offering price reductions (cash discounts) and payments falls outside the EU law concept of medicinal product advertising. Recently, in a…

Read More
In Medical Devices

Mitigating Risk in Life Sciences Acquisitions

by 8 Mins Read

In the race to innovate, life sciences companies are betting big on M&A, but navigating the risks requires smarter deal structures Big pharmaceutical companies facing patent cliffs. MedTech companies seeking access to the latest AI technologies. Across the life sciences industry, companies have strong incentives to use M&A to grow their product pipelines, enhance their existing product offerings, and gain access to new markets. But, at what cost? Less than half of phase II clinical…

Read More
In Medical Devices

The EU restricts access of Chinese medical devices to the European market

by , and 8 Mins Read

Commission enacts first Implementing Regulation under the EU’s International Procurement Instrument – and the Chinese Government promptly retaliates For the first time, the European Commission completed an investigation under the International Procurement Instrument (IPI) and implemented measures to limit the participation of economic operators from non-EU countries – in this particular case, China – in the EU public procurement market. After EU suppliers of medical devices have arguably been denied fair access to Chinese government…

Read More